Conjunctivitis medical therapy: Difference between revisions
No edit summary |
|||
Line 14: | Line 14: | ||
Shown below tables of conjunctivitis medical therapy:<ref name="pmid23114684">{{cite journal| author=| title=Drugs for some common eye disorders. | journal=Treat Guidel Med Lett | year= 2012 | volume= 10 | issue= 123 | pages= 79-86; quiz 2 p following 86 | pmid=23114684 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23114684 }} </ref> | Shown below tables of conjunctivitis medical therapy:<ref name="pmid23114684">{{cite journal| author=| title=Drugs for some common eye disorders. | journal=Treat Guidel Med Lett | year= 2012 | volume= 10 | issue= 123 | pages= 79-86; quiz 2 p following 86 | pmid=23114684 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23114684 }} </ref> | ||
<SMALL><font color="#FF4C4C">'''▸ Click on the following categories to expand treatment regimens.'''</font></SMALL> | |||
{| | |||
| valign=top | | |||
<div style="border-radius: 5px 5px 0 0; border: solid 1px #20538D; border-bottom: 0px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 225px; background: #A1BCDD; text-align: center;"> | |||
<font color="#FFF"> | |||
'''Conjunctivitis Medical Therapy''' | |||
</font> | |||
</div> | |||
<div class="mw-customtoggle-table12" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 225px; background: #4479BA;"> | |||
<font color="#FFF"> | |||
▸ '''Bacterial Conjunctivitis''' | |||
</font> | |||
</div> | |||
<div class="mw-customtoggle-table14" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 225px; background: #4479BA;"> | |||
<font color="#FFF"> | |||
▸ '''Newborn Conjunctivitis''' | |||
</font> | |||
</div> | |||
<div class="mw-customtoggle-table15" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 225px; background: #4479BA;"> | |||
<font color="#FFF"> | |||
▸ '''Viral Conjunctivitis''' | |||
</font> | |||
</div> | |||
| valign=top | | |||
{| class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table12" style="background: #FFFFFF;" | |||
| valign=top | | |||
{| style="float: left; cellpadding=0; cellspacing= 0; width: 400px;" | |||
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Bacterial Conjunctivitis}} | |||
|- | |||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''Preferred Regimen''''' | |||
|- | |||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align= Left | '''''Non-gonococcal''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ciprofloxacin]] 1–2 gtts q2h while awake x 1st 2 days, then q4–8h x 7 days'''''<BR> OR <BR>▸ '''''[[Gatifloxacin]] 1–2 gtts q2h while awake x 1st 2 days, then q4–8h x 7 days'''''<BR> OR <BR>▸ '''''[[Levofloxacin]] 1–2 gtts q2h while awake x 1st 2 days, then q4–8h x 7 days'''''<BR> OR <BR>▸ '''''[[Moxifloxacin]] 1–2 gtts q2h while awake x 1st 2 days, then q4–8h x 7 days''''' | |||
|- | |||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align= Left | '''''Gonococcal''''' | |||
|- | |||
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Adult dose}}'' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ciprofloxacin]] 1 gm IM/IV as 1 dose''''' | |||
|- | |||
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Pediatric dose}}'' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ciprofloxacin]] 25-50 mg/kg IV/IM (not to exceed 125 mg) as 1 dose''''' | |||
|- | |||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''Alternative Regimen (for non-gonococcal only)''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Polymyxin B]] + [[Trimethoprim]] 1–2 gtts q3–6h x 7–10 days'''''<BR> OR <BR> ▸ '''''[[Azithromycin ]] 1%, 1 gtt bid x 2 days, then 1 gtt daily x 5 days''''' | |||
|- | |||
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Chlamydia Trachomatis}} | |||
|- | |||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''Preferred Regimen''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Azithromycin]] 1 gm once or twice weekly''''' | |||
|- | |||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''Alternative Regimen''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Doxycycline]] 100 mg bid po x 7 days''''' | |||
|- | |||
|} | |||
|} | |||
{| class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table14" style="background: #FFFFFF;" | |||
| valign=top | | |||
{| style="float: left; cellpadding=0; cellspacing= 0; width: 400px;" | |||
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Newborn Conjunctivitis}} | |||
|- | |||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | ''''' [[Neisseria gonorrhoeae]] (after 2-5 days)''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ceftriaxone]] 25-50 mg/kg IV x 1 dose (not to exceed 125 mg)''''' | |||
|- | |||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | ''''' [[Chlamydia trachomatis]] (after 3-10 days)''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Erythromycin]] base or ethyl succinate syrup 12.5 mg/kg q6h x 14 days'''''<BR> OR <BR> ▸ '''''[[Azithromycin ]] suspension 20 mg/kg po q24h x 3 days''''' | |||
|- | |||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''[[Herpes simplex]] (after 2-16 days) †''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Acyclovir]] 60 mg/kg/day IV divided into 3 daily doses'''''<BR> OR <BR> ▸ '''''[[Trifluridine]] OR [[Vidarabine]] as a topical antiviral therapy''''' | |||
|- | |||
|† Systemic and CNS disease should be evaluated with PCR of CSF and serum and LFTs in any child with suspected HSV eye infection. | |||
|- | |||
|} | |||
|} | |||
{| class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table15" style="background: #FFFFFF;" | |||
| valign=top | | |||
{| style="float: left; cellpadding=0; cellspacing= 0; width: 400px;" | |||
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Viral Conjunctivitis (pink eye)}} | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''No treatment, but if symptomatic, use cold artificial tears''''' | |||
|- | |||
|} | |||
|} | |||
|} | |||
==References== | ==References== |
Revision as of 20:18, 3 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Conjunctivitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Conjunctivitis medical therapy On the Web |
American Roentgen Ray Society Images of Conjunctivitis medical therapy |
Risk calculators and risk factors for Conjunctivitis medical therapy |
Medical Therapy
Pharmacotherapy
Acute Pharmacotherapies
Conjunctivitis sometimes requires medical attention. The appropriate treatment depends on the cause of the problem. For the allergic type, cool water constricts capillaries, and artificial tears sometimes relieve discomfort in mild cases. In more severe cases, non-steroidal anti-inflammatory medications and antihistamines may be prescribed. Some patients with persistent allergic conjunctivitis may also require topical steroid drops.
Bacterial conjunctivitis is usually treated with antibiotic eye drops or ointments that cover a broad range of bacteria (chloramphenicol or fusidic acid used in UK). However evidence suggests that this does not affect symptom severity and gains only modest reduction in duration from an average of 4.8 days (untreated controls) to 3.3 days for those given immediate antibiotics. Deferring antibiotics yields almost the same duration as those immediately starting treatment with 3.9 days duration, but with half the two-week clinic reattendance rate.[1]
Although there is no cure for viral conjunctivitis, symptomatic relief may be achieved with cool compresses and artificial tears. For the worst cases, topical corticosteroid drops may be prescribed to reduce the discomfort from inflammation. However prolonged usage of corticosteroid drops increases the risk of side effects. Antibiotic drops may also be used for treatment of complementary infections. Patients are often advised to avoid touching their eyes or sharing towels and washcloths. Viral conjunctivitis usually resolves within 3 weeks. However in worst cases it may take over a month.
Conjunctivitis due to burns, toxic and chemical require careful wash-out with saline, especially beneath the lids, and may require topical steroids. The more acute chemical injuries are medical emergencies, particularly alkali burns, which can lead to severe scarring, and intraocular damage. Fortunately, such injuries are uncommon.
Shown below tables of conjunctivitis medical therapy:[2]
▸ Click on the following categories to expand treatment regimens.
Conjunctivitis Medical Therapy ▸ Bacterial Conjunctivitis ▸ Newborn Conjunctivitis ▸ Viral Conjunctivitis |
|
References
- ↑ Hazel A Everitt, Paul S Little, Peter W F Smith (2006). "A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice". BMJ. Error: Bad DOI specified!. Unknown parameter
|month=
ignored (help) - ↑ "Drugs for some common eye disorders". Treat Guidel Med Lett. 10 (123): 79–86, quiz 2 p following 86. 2012. PMID 23114684.